TipRanks
Go Ultimate55% OFF

Inhibikase Therapeutics (IKT) Market Cap & Net Worth

379 Followers

Inhibikase Therapeutics Market Cap

Inhibikase Therapeutics has a market cap or net worth of $214.89M as of Nov 04, 2026. Its market cap has increase by 81.37% in one year.

Market Cap
$214.89M
Enterprise Value
$195.36M
1-Year Change
81.37%
Category
Micro (Under 300M)
Stock Price
$1.48

Market Cap Chart

0.00100.00M200.00M300.00M400.00MNov 21Nov 22Nov 23Nov 24Nov 25
Market Cap History
Download to Excel
IKT market cap history
DateMarket Cap% Change
Nov 03, 2026206.51M-3.90%
Nov 02, 2026214.89M-0.65%
Oct 30, 2026216.28M-7.19%
Oct 29, 2026233.02M+3.09%
Oct 28, 2026226.05M+3.18%
Oct 27, 2026219.07M+3.29%
Oct 26, 2026212.09M-4.40%
Oct 23, 2026221.86M-2.45%
Oct 22, 2026227.44M-1.81%
Oct 21, 2026231.63M-2.92%
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Related stocks
CompanyMarket Cap
IKT$214.89M
ATOS$22.95M
ANIX$103.94M
SPRO$60.56M
SRZN$341.09M
TCRX$12.15M